title: Preliminary investigation of the area under the L-lactate concentration-time curve (LACArea) in critically ill equine neonates.
abstract: BACKGROUND
  A variety of measures of L-lactate concentration ([LAC]) in the blood of critically ill neonatal foals have shown utility as prognostic indicators. These measures, evaluating either the severity of hyperlactatemia or the duration of exposure to hyperlactatemia, perform fairly well and have correctly classified 75-80% of foals examined in several studies. The area under the L-lactate concentration versus time curve (LACArea) encompasses both severity and duration of hyperlactatemia and should improve correct classification of patient survival.
  
  
  OBJECTIVE
  LACArea is larger in nonsurviving critically ill neonatal foals.
  
  
  METHODS
  Forty-nine foals admitted for critical illness to 1 of 4 referral hospitals.
  
  
  METHODS
  Whole blood was obtained at admission and 6, 12, 18, and 24 hours after admission for measurement of L-lactate using a handheld lactate meter. LACArea was calculated for: admission-6, 6-12, 12-18, 18-24 hours, and admission-24 hours using the trapezoidal method and summing the 6-hours interval areas to determine total 24 hours area. Differences between survivors and nonsurvivors were determined using robust regression and Kruskal-Wallis testing, P < .05.
  
  
  RESULTS
  LACArea was significantly larger in nonsurviving foals (n = 9) than in surviving foals (n = 40) at all time periods examined.
  
  
  CONCLUSIONS
  Differences in LACArea between surviving and nonsurviving critically ill neonatal foals are large and support further investigation of this method as an improved biomarker for survival in critically ill neonatal foals is indicated.
authors.affiliation: Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL.
authors.forename: P A
authors.initials: PA
authors.lastname: Wilkins
authors.forename: B J
authors.initials: BJ
authors.lastname: Sheahan
authors.forename: K A
authors.initials: KA
authors.lastname: Vander Werf
authors.forename: C
authors.initials: C
authors.lastname: Castagnetti
authors.forename: J
authors.initials: J
authors.lastname: Hardy
authors.forename: A
authors.initials: A
authors.lastname: Schoster
authors.forename: R C
authors.initials: RC
authors.lastname: Boston
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D019540:Area Under Curve; D015415:Biomarkers / Q000097:blood; D016638:Critical Illness; D006734:Horse Diseases / Q000097:blood* / Q000378:metabolism; D006736:Horses; D019344:Lactic Acid / Q000097:blood*; D016019:Survival Analysis
chemical_list: D015415:Biomarkers; D019344:Lactic Acid
keywords: Horse; Hyperlactatemia; Intensive care; Lactate clearance; Survival
references.citation: Theriogenology. 2010 Feb;73(3):343-57
references.pmid: 19962183
references.citation: Equine Vet J Suppl. 2012 Feb;(41):57-63
references.pmid: 22594028
references.citation: Intensive Care Med. 2013 Oct;39(10):1818-23
references.pmid: 23818093
references.citation: Theriogenology. 2012 Oct 1;78(6):1182-9
references.pmid: 22898010
references.citation: J Vet Emerg Crit Care (San Antonio). 2016 Mar-Apr;26(2):305-9
references.pmid: 26595884
references.citation: Reprod Nutr Dev. 2003 Jan-Feb;43(1):1-15
references.pmid: 12785446
references.citation: Equine Vet J Suppl. 2013 Dec;(45):2-7
references.pmid: 24304396
references.citation: J Vet Intern Med. 2009 May-Jun;23(3):598-605
references.pmid: 19317836
references.citation: J Pharmacokinet Biopharm. 1992 Jun;20(3):211-26
references.pmid: 1522479